3T6P image
Deposition Date 2011-07-28
Release Date 2011-11-02
Last Version Date 2024-02-28
Entry Detail
PDB ID:
3T6P
Keywords:
Title:
IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerization
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Baculoviral IAP repeat-containing protein 2
Gene (Uniprot):BIRC2
Mutations:F378Y
Chain IDs:A
Chain Length:345
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination.
Science 334 376 380 (2011)
PMID: 22021857 DOI: 10.1126/science.1207862

Abstact

Inhibitor of apoptosis (IAP) proteins are negative regulators of cell death. IAP family members contain RING domains that impart E3 ubiquitin ligase activity. Binding of endogenous or small-molecule antagonists to select baculovirus IAP repeat (BIR) domains within cellular IAP (cIAP) proteins promotes autoubiquitination and proteasomal degradation and so releases inhibition of apoptosis mediated by cIAP. Although the molecular details of antagonist-BIR domain interactions are well understood, it is not clear how this binding event influences the activity of the RING domain. Here biochemical and structural studies reveal that the unliganded, multidomain cIAP1 sequesters the RING domain within a compact, monomeric structure that prevents RING dimerization. Antagonist binding induces conformational rearrangements that enable RING dimerization and formation of the active E3 ligase.

Legend

Protein

Chemical

Disease

Primary Citation of related structures